Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis; Ixora-peds

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleStudy of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis; Ixora-peds
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsJohn C Browning